scholarly journals Assessing Bladder Cancer Risk in Type 2 Diabetes Clinical Trials: the Dapagliflozin Drug Development Program as a ‘Case Study’

2015 ◽  
Vol 6 (3) ◽  
pp. 357-375 ◽  
Author(s):  
Agata Ptaszynska ◽  
Samuel M. Cohen ◽  
Edward M. Messing ◽  
Timothy P. Reilly ◽  
Eva Johnsson ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Bladder Cancer ◽  
Clinical Trials ◽  
Cancer Risk ◽  
Drug Development ◽  
Development Program ◽  
Bladder Cancer Risk ◽  
Drug Development Program

scholarly journals The association between type 2 diabetes mellitus and bladder cancer risk among postmenopausal women

2020 ◽  
Vol 31 (5) ◽  
pp. 503-510
Author(s):  
Yueyao Li ◽  
Michael S. Hendryx ◽  
Pengcheng Xun ◽  
Ka He ◽  
Aladdin H. Shadyab ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Bladder Cancer ◽  
Type 2 Diabetes Mellitus ◽  
Cancer Risk ◽  
Postmenopausal Women ◽  
Bladder Cancer Risk

scholarly journals Detection Bias and Overestimation of Bladder Cancer Risk in Type 2 Diabetes: A matched cohort study

Diabetes Care ◽  
2013 ◽  
Vol 36 (10) ◽  
pp. 3070-3075 ◽  
Author(s):  
I. N. Colmers ◽  
S. R. Majumdar ◽  
Y. Yasui ◽  
S. L. Bowker ◽  
C. A. Marra ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Bladder Cancer ◽  
Cohort Study ◽  
Cancer Risk ◽  
Matched Cohort ◽  
Bladder Cancer Risk ◽  
Detection Bias ◽  
Matched Cohort Study

scholarly journals Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients

Medicine ◽  
2018 ◽  
Vol 97 (30) ◽  
pp. e11596 ◽  
Author(s):  
Jiao Hu ◽  
Jin-bo Chen ◽  
Yu Cui ◽  
Ye-wen Zhu ◽  
Wen-biao Ren ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Bladder Cancer ◽  
Type 2 Diabetes Mellitus ◽  
Cancer Risk ◽  
Oncologic Outcomes ◽  
Bladder Cancer Risk

A Systematic Assessment of Cardiovascular Outcomes in the Saxagliptin Drug Development Program for Type 2 Diabetes

2010 ◽  
Vol 122 (3) ◽  
pp. 16-27 ◽  
Author(s):  
Robert Frederich ◽  
John H. Alexander ◽  
Fred T. Fiedorek ◽  
Mark Donovan ◽  
Niklas Berglind ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Drug Development ◽  
Development Program ◽  
Cardiovascular Outcomes ◽  
Systematic Assessment ◽  
Drug Development Program
Sign in / Sign up

Export Citation Format

Share Document